We also found that the treatment with Fer-1 and DFO could reverse the combined anti-tumor effects of Sorafenib and PTGDS knockdown in PTCL cells (Supplementary Fig. S5), indicating that ferroptosis played important role in the inhibitory effects. This evidence concerns the gene PTGDS and mature T-cell and NK-cell non-Hodgkin lymphoma.